Synthesis, Characterization, and Magnetic Properties of Fe(BIP)3, a Novel Paramagnetic Relaxation Agent
Abstract
1. Introduction
2. Results and Discussion
2.1. Synthesis
2.2. Characterization of Fe(BIP)3
2.3. X-Ray Diffraction Analysis
2.4. Preparation, Characterization, and Stabilization of the Aggregates
2.4.1. Preparation and Characterization
2.4.2. Stabilization
2.5. Relaxivity Measurements
3. Materials and Methods
3.1. Fe(BIP)3 Synthesis and Characterization
3.2. X-Ray Structural Analysis
3.3. Liposome Preparation
3.3.1. Direct Mixing Protocol
3.3.2. Thin Film Protocol
3.4. Characterization of Fe(BIP)3 Aggregates and Liposomes
3.4.1. Fluorescence Spectroscopy
3.4.2. Dynamic Light Scattering
3.4.3. Scanning Electron Microscopy
3.4.4. Fluorescence Correlation Spectroscopy
3.5. Relaxivity Measurements
4. Conclusions
- Fe(BIP)3 was fully characterized by UV-Vis and FTIR spectroscopy, single-crystal X-ray diffraction, and magnetic susceptibility measurements, confirming a high-spin configuration (S = 5/2) with an effective magnetic moment of 6.4 Bohr magnetons.
- The complex spontaneously aggregates into morphologically homogeneous, rice-grain-shaped nanoparticles with an average hydrodynamic radius of ~30 nm when percolated in aqueous solution.
- These metastable aggregates can be stabilized through incorporation into soybean lecithin vesicles, as demonstrated by combined DLS, FCS and FRET experiments.
- Relaxivity measurements at 9.4 T yielded r1 = 1.92 mM−1s−1 and r2 = 52.3 mM−1s−1, with an r2/r1 ratio of 27.2, consistent with T2 contrast agent behavior.
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
| Fe(BIP)3 | |
|---|---|
| Chemical formula | C63H51FeN6O6·2(C4H9NO)·H2O |
| CCDC number | 2483872 |
| Mr | 1236.20 |
| Crystal system, space group | Orthorhombic, Pccn |
| Temperature (K) | 100 |
| a, b, c (Å) | 11.0479 (2), 27.6020 (6), 20.5711 (3) |
| V (Å3) | 6273.0 (2) |
| Z | 4 |
| Radiation type | Cu Kα |
| μ (mm−1) | 2.46 |
| Crystal size (mm) | 0.14 × 0.07 × 0.04 |
| Diffractometer | XtaLAB Synergy, single source at home/near, HyPix |
| Absorption correction | Numerical/face-indexed |
| Tmin, Tmax | 0.79, 1.00 |
| No. of measured, independent and observed [I > 2σ(I)] reflections | 49455, 5519, 4790 |
| Rint | 0.146 |
| (sin θ/λ)max (Å−1) | 0.595 |
| R[F2 > 2σ(F2)], wR(F2), S | 0.069, 0.198, 1.04 |
| No. of reflections | 5519 |
| No. of parameters | 415 |
| No. of restraints | 3 |
| H atom treatment | H atoms treated by a mixture of independent and constrained refinement |
| Δñmax, Δñmin (e Å−3) | 1.01, −0.66 |
References
- Theil, E.C.; Goss, D.J. Living with Iron (and Oxygen): Questions and Answers about Iron Homeostasis. Chem. Rev. 2009, 109, 4568–4579. [Google Scholar] [CrossRef]
- Lasocki, S.; Gaillard, T.; Rineau, E. Iron Is Essential for Living! Crit. Care 2014, 18, 678. [Google Scholar] [CrossRef]
- Sánchez, M.; Sabio, L.; Gálvez, N.; Capdevila, M.; Dominguez-Vera, J.M. Iron Chemistry at the Service of Life. IUBMB Life 2017, 69, 382–388. [Google Scholar] [CrossRef] [PubMed]
- Mills, K.C.; Curry, S.C. Acute Iron Poisoning. Emerg. Med. Clin. N. Am. 1994, 12, 397–413. [Google Scholar] [CrossRef]
- Bezkorovainy, A. Chemistry and Biology of Iron Storage. In Biochemistry of Nonheme Iron; Springer: Boston, MA, USA, 1980; pp. 207–269. [Google Scholar] [CrossRef]
- Abadía, J.; Vázquez, S.; Rellán-Álvarez, R.; El-Jendoubi, H.; Abadía, A.; Álvarez-Fernández, A.; López-Millán, A.F. Towards a Knowledge-Based Correction of Iron Chlorosis. Plant Physiol. Biochem. 2011, 49, 471–482. [Google Scholar] [CrossRef]
- Pasricha, S.-R.; Tye-Din, J.; Muckenthaler, M.U.; Swinkels, D.W. Iron Deficiency. Lancet 2021, 397, 233–248. [Google Scholar] [CrossRef]
- Papanikolaou, G.; Pantopoulos, K. Iron Metabolism and Toxicity. Toxicol. Appl. Pharmacol. 2005, 202, 199–211. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.-K.; Lee, G.H.; Chang, Y. Gadolinium as an MRI Contrast Agent. Future Med. Chem. 2018, 10, 639–661. [Google Scholar] [CrossRef]
- Grobner, T.; Prischl, F.C. Gadolinium and Nephrogenic Systemic Fibrosis. Kidney Int. 2007, 72, 260–264. [Google Scholar] [CrossRef]
- Kanda, T.; Fukusato, T.; Matsuda, M.; Toyoda, K.; Oba, H.; Kotoku, J.; Haruyama, T.; Kitajima, K.; Furui, S. Gadolinium-Based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Radiology 2015, 276, 228–232. [Google Scholar] [CrossRef]
- Layne, K.A.; Dargan, P.I.; Archer, J.R.H.; Wood, D.M. Gadolinium Deposition and the Potential for Toxicological Sequelae–A Literature Review of Issues Surrounding Gadolinium-based Contrast Agents. Brit J. Clin. Pharma 2018, 84, 2522–2534. [Google Scholar] [CrossRef]
- Gadolinium-Containing Contrast Agents–Referral|European Medicines Agency (EMA). Available online: https://www.ema.europa.eu/en/medicines/human/referrals/gadolinium-containing-contrast-agents (accessed on 6 October 2025).
- Kanda, T. The New Restrictions on the Use of Linear Gadolinium-Based Contrast Agents in Japan. MRMS 2019, 18, 1–3. [Google Scholar] [CrossRef]
- May, D.; Prior, T.; Cordell, D.; Giurco, D. Peak Minerals: Theoretical Foundations and Practical Application. Nat. Resour. Res. 2012, 21, 43–60. [Google Scholar] [CrossRef]
- Wellmer, F.-W.; Scholz, R.W. Peak Minerals: What Can We Learn from the History of Mineral Economics and the Cases of Gold and Phosphorus? Min. Econ. 2017, 30, 73–93. [Google Scholar] [CrossRef]
- Gupta, A.; Caravan, P.; Price, W.S.; Platas-Iglesias, C.; Gale, E.M. Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging. Inorg. Chem. 2020, 59, 6648–6678. [Google Scholar] [CrossRef]
- Kuźnik, N.; Wyskocka, M. Iron(III) Contrast Agent Candidates for MRI: A Survey of the Structure–Effect Relationship in the Last 15 Years of Studies. Eur. J. Inorg. Chem. 2016, 2016, 445–458. [Google Scholar] [CrossRef]
- Kras, E.A.; Snyder, E.M.; Sokolow, G.E.; Morrow, J.R. Distinct Coordination Chemistry of Fe(III)-Based MRI Probes. Acc. Chem. Res. 2022, 55, 1435–1444. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; An, L.; Yang, S. Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents. Molecules 2022, 27, 4573. [Google Scholar] [CrossRef]
- Worah, D.; Berger, A.E.; Burnett, K.R.; Howard, H.; Kanal, E.; Kendall, C.; Leese, P.T.; Lyons, K.P.; Ross, E.; Wolf, G.L.; et al. Ferrioxamine as a Magnetic Resonance Contrast Agent Preclinical Studies and Phase I and II Human Clinical Trials. Investig. Radiol. 1988, 23, S281–S285. [Google Scholar] [CrossRef]
- Bertini, I.; Capozzi, F.; Luchinat, C.; Xia, Z. Nuclear and Electron Relaxation of Hexaaquairon(3+). J. Phys. Chem. 1993, 97, 1134–1137. [Google Scholar] [CrossRef]
- Luchinat, C. Relaxometry and Paramagnetic Metal Ions in Biological Systems. Magn. Reson. Chem. 1993, 31, S145–S153. [Google Scholar] [CrossRef]
- Drahoš, B.; Lukeš, I.; Tóth, É. Manganese(II) Complexes as Potential Contrast Agents for MRI. Eur. J. Inorg. Chem. 2012, 2012, 1975–1986. [Google Scholar] [CrossRef]
- Toth, G.B.; Varallyay, C.G.; Horvath, A.; Bashir, M.R.; Choyke, P.L.; Daldrup-Link, H.E.; Dosa, E.; Finn, J.P.; Gahramanov, S.; Harisinghani, M.; et al. Current and Potential Imaging Applications of Ferumoxytol for Magnetic Resonance Imaging. Kidney Int. 2017, 92, 47–66. [Google Scholar] [CrossRef]
- Jeon, M.; Halbert, M.V.; Stephen, Z.R.; Zhang, M. Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives. Adv. Mater. 2021, 33, 1906539. [Google Scholar] [CrossRef]
- Chen, C.; Ge, J.; Gao, Y.; Chen, L.; Cui, J.; Zeng, J.; Gao, M. Ultrasmall Superparamagnetic Iron Oxide Nanoparticles: A next Generation Contrast Agent for Magnetic Resonance Imaging. WIREs Nanomed. Nanobiotechnol. 2022, 14, e1740. [Google Scholar] [CrossRef]
- Palagi, L.; Di Gregorio, E.; Costanzo, D.; Stefania, R.; Cavallotti, C.; Capozza, M.; Aime, S.; Gianolio, E. Fe(Deferasirox)2: An Iron(III)-Based Magnetic Resonance Imaging T1 Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics. J. Am. Chem. Soc. 2021, 143, 14178–14188. [Google Scholar] [CrossRef] [PubMed]
- Bales, B.C.; Grimmond, B.; Johnson, B.F.; Luttrell, M.T.; Meyer, D.E.; Polyanskaya, T.; Rishel, M.J.; Roberts, J. Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging. Contrast Media Mol. Imaging 2019, 2019, 8356931. [Google Scholar] [CrossRef]
- Xie, J.; Haeckel, A.; Hauptmann, R.; Ray, I.P.; Limberg, C.; Kulak, N.; Hamm, B.; Schellenberger, E. Iron(III)-t CDTA Derivatives as MRI Contrast Agents: Increased T1 Relaxivities at Higher Magnetic Field Strength and pH Sensing. Magn. Reson. Med. 2021, 85, 3370–3382. [Google Scholar] [CrossRef]
- Iv, M.; Telischak, N.; Feng, D.; Holdsworth, S.J.; Yeom, K.W.; Daldrup-Link, H.E. Clinical Applications of Iron Oxide Nanoparticles for Magnetic Resonance Imaging of Brain Tumors. Nanomedicine 2015, 10, 993–1018. [Google Scholar] [CrossRef]
- Shen, Z.; Wu, A.; Chen, X. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging. Mol. Pharm. 2017, 14, 1352–1364. [Google Scholar] [CrossRef] [PubMed]
- Wáng, Y.X.J.; Idée, J.-M. A Comprehensive Literatures Update of Clinical Researches of Superparamagnetic Resonance Iron Oxide Nanoparticles for Magnetic Resonance Imaging. Quant. Imaging Med. Surg. 2017, 7, 88–122. [Google Scholar] [CrossRef]
- Bao, Y.; Sherwood, J.A.; Sun, Z. Magnetic Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging. J. Mater. Chem. C 2018, 6, 1280–1290. [Google Scholar] [CrossRef]
- Zhao, Z.; Li, M.; Zeng, J.; Huo, L.; Liu, K.; Wei, R.; Ni, K.; Gao, J. Recent Advances in Engineering Iron Oxide Nanoparticles for Effective Magnetic Resonance Imaging. Bioact. Mater. 2022, 12, 214–245. [Google Scholar] [CrossRef] [PubMed]
- Rahman, M. Magnetic Resonance Imaging and Iron-Oxide Nanoparticles in the Era of Personalized Medicine. Nanotheranostics 2023, 7, 424–449. [Google Scholar] [CrossRef]
- Aboushoushah, S.F.O. Iron Oxide Nanoparticles Enhancing Magnetic Resonance Imaging: A Review of the Latest Advancements. J. Sci. Adv. Mater. Devices 2025, 10, 100875. [Google Scholar] [CrossRef]
- Singh, A.; Kumar, P.; Pathak, S.; Jain, K.; Garg, P.; Pant, M.; Mahapatro, A.K.; Singh, R.K.; Rajput, P.; Kim, S.-K.; et al. Tailored Nanoparticles for Magnetic Hyperthermia: Highly Stable Aqueous Dispersion of Mn-Substituted Magnetite Superparamagnetic Nanoparticles by Double Surfactant Coating for Improved Heating Efficiency. J. Alloys Compd. 2024, 976, 172999. [Google Scholar] [CrossRef]
- Singh, P.; Pandit, S.; Balusamy, S.R.; Madhusudanan, M.; Singh, H.; Amsath Haseef, H.M.; Mijakovic, I. Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications. Adv. Healthc. Mater. 2025, 14, 2403059. [Google Scholar] [CrossRef]
- Carrano, C.J.; Drechsel, H.; Kaiser, D.; Jung, G.; Matzanke, B.; Winkelmann, G.; Rochel, N.; Albrecht-Gary, A.M. Coordination Chemistry of the Carboxylate Type Siderophore Rhizoferrin: The Iron(III) Complex and Its Metal Analogs. Inorg. Chem. 1996, 35, 6429–6436. [Google Scholar] [CrossRef]
- Hider, R.C.; Silva, A.M.N.; Cilibrizzi, A. The Iron(III) Coordinating Properties of Citrate and α-Hydroxycarboxylate Containing Siderophores. Biometals 2024, 14, 121072. [Google Scholar] [CrossRef] [PubMed]
- Al Shaer, D.; Al Musaimi, O.; De La Torre, B.G.; Albericio, F. Hydroxamate Siderophores: Natural Occurrence, Chemical Synthesis, Iron Binding Affinity and Use as Trojan Horses against Pathogens. Eur. J. Med. Chem. 2020, 208, 112791. [Google Scholar] [CrossRef]
- Raymond, K.N.; Dertz, E.A.; Kim, S.S. Enterobactin: An Archetype for Microbial Iron Transport. Proc. Natl. Acad. Sci. USA 2003, 100, 3584–3588. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Wen, J.; Qin, M.; Cao, Y.; Ma, H.; Wang, W. Single-Molecule Mechanics of Catechol-Iron Coordination Bonds. ACS Biomater. Sci. Eng. 2017, 3, 979–989. [Google Scholar] [CrossRef] [PubMed]
- Benassi, R.; Ferrari, E.; Grandi, R.; Lazzari, S.; Saladini, M. Synthesis and Characterization of New β-Diketo Derivatives with Iron Chelating Ability. J. Inorg. Biochem. 2007, 101, 203–213. [Google Scholar] [CrossRef]
- Li, K.; Amann, T.; Walter, M.; Moseler, M.; Kailer, A.; Rühe, J. Ultralow Friction Induced by Tribochemical Reactions: A Novel Mechanism of Lubrication on Steel Surfaces. Langmuir 2013, 29, 5207–5213. [Google Scholar] [CrossRef]
- Walter, M.; Amann, T.; Li, K.; Kailer, A.; Rühe, J.; Moseler, M. 1,3-Diketone Fluids and Their Complexes with Iron. J. Phys. Chem. A 2013, 117, 3369–3376. [Google Scholar] [CrossRef]
- Kislukhin, A.A.; Xu, H.; Adams, S.R.; Narsinh, K.H.; Tsien, R.Y.; Ahrens, E.T. Paramagnetic Fluorinated Nanoemulsions for Sensitive Cellular Fluorine-19 Magnetic Resonance Imaging. Nat. Mater. 2016, 15, 662–668. [Google Scholar] [CrossRef]
- Jahromi, A.H.; Wang, C.; Adams, S.R.; Zhu, W.; Narsinh, K.; Xu, H.; Gray, D.L.; Tsien, R.Y.; Ahrens, E.T. Fluorous-Soluble Metal Chelate for Sensitive Fluorine-19 Magnetic Resonance Imaging Nanoemulsion Probes. ACS Nano 2019, 13, 143–151. [Google Scholar] [CrossRef]
- Wang, C.; Adams, S.R.; Xu, H.; Zhu, W.; Ahrens, E.T. β-Diketonate-Iron(III) Complex: A Versatile Fluorine-19 MRI Signal Enhancement Agent. ACS Appl. Bio Mater. 2019, 2, 3836–3842. [Google Scholar] [CrossRef] [PubMed]
- Scapinello, L.; Vesco, G.; Nardo, L.; Maspero, A.; Vavassori, F.; Galli, S.; Penoni, A. Synthesis, Characterization and DNA-Binding Affinity of a New Zinc(II) Bis(5-Methoxy-Indol-3-Yl)Propane-1,3-Dione Complex. Pharmaceuticals 2021, 14, 760. [Google Scholar] [CrossRef]
- Maspero, A.; Vavassori, F.; Nardo, L.; Vesco, G.; Vitillo, J.G.; Penoni, A. Synthesis, Characterization, Fluorescence Properties, and DFT Modeling of Difluoroboron Biindolediketonates. Molecules 2023, 28, 4688. [Google Scholar] [CrossRef]
- Diana, P.; Carbone, A.; Barraja, P.; Martorana, A.; Gia, O.; DallaVia, L.; Cirrincione, G. 3,5-Bis(3′-Indolyl)Pyrazoles, Analogues of Marine Alkaloid Nortopsentin: Synthesis and Antitumor Properties. Bioorganic Med. Chem. Lett. 2007, 17, 6134–6137. [Google Scholar] [CrossRef]
- Diana, P.; Carbone, A.; Barraja, P.; Kelter, G.; Fiebig, H.-H.; Cirrincione, G. Synthesis and Antitumor Activity of 2,5-Bis(3′-Indolyl)-Furans and 3,5-Bis(3′-Indolyl)-Isoxazoles, Nortopsentin Analogues. Bioorganic Med. Chem. 2010, 18, 4524–4529. [Google Scholar] [CrossRef] [PubMed]
- Carbone, A.; Spanò, V.; Parrino, B.; Ciancimino, C.; Attanasi, O.; Favi, G. A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin. Molecules 2013, 18, 2518–2527. [Google Scholar] [CrossRef] [PubMed]
- Carbone, A.; Parrino, B.; Barraja, P.; Spanò, V.; Cirrincione, G.; Diana, P.; Maier, A.; Kelter, G.; Fiebig, H.-H. Synthesis and Antiproliferative Activity of 2,5-Bis(3′-Indolyl)Pyrroles, Analogues of the Marine Alkaloid Nortopsentin. Mar. Drugs 2013, 11, 643–654. [Google Scholar] [CrossRef]
- Thornton, D.A. Infrared Spectra of Metal β-Ketoenolates and Related Complexes. Coord. Chem. Rev. 1990, 104, 173–249. [Google Scholar] [CrossRef]
- Nekoei, A.-R.; Vakili, M.; Hakimi-Tabar, M.; Tayyari, S.F.; Afzali, R.; Kjaergaard, H.G. Theoretical Study, and Infrared and Raman Spectra of Copper(II) Chelated Complex with Dibenzoylmethane. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 128, 272–279. [Google Scholar] [CrossRef]
- Prashanth, J.; Ramesh, G.; Naik, J.L.; Ojha, J.K.; Reddy, B.V.; Rao, G.R. Molecular Structure, Vibrational Analysis and First Order Hyperpolarizability of 4-Methyl-3-Nitrobenzoic Acid Using Density Functional Theory. Opt. Photonics J. 2015, 05, 91–107. [Google Scholar] [CrossRef]
- Lintvedt, R.L.; Kernitsky, L.K. Ligand Field Information from Charge-Transfer Spectra of Substituted Tris(1,3-Diketonato)Iron(III) Chelates. Spectrochemical Series for 1,3-Diketones. Inorg. Chem. 1970, 9, 491–494. [Google Scholar] [CrossRef]
- Conradie, M.M. UV-Vis Spectroscopy, Electrochemical and DFT Study of Tris(β-Diketonato)Iron(III) Complexes with Application in DSSC: Role of Aromatic Thienyl Groups. Molecules 2022, 27, 3743. [Google Scholar] [CrossRef]
- Bain, G.A.; Berry, J.F. Diamagnetic Corrections and Pascal’s Constants. J. Chem. Educ. 2008, 85, 532. [Google Scholar] [CrossRef]
- Uchida, M.; Cortney, C.H.; Bustos, K.; Manzo, E.; Sauls, E.; Bouchard, J.; Fukazawa, R.; Krishnan, V.V. Discovery-Based Approach to Identify Multiple Factors That Affect the Spin State of Coordination Complexes Using the Evans NMR Method. J. Chem. Educ. 2023, 100, 4822–4827. [Google Scholar] [CrossRef]
- Bruno, I.J.; Cole, J.C.; Kessler, M.; Luo, J.; Motherwell, W.D.S.; Purkis, L.H.; Smith, B.R.; Taylor, R.; Cooper, R.I.; Harris, S.E.; et al. Retrieval of Crystallographically-Derived Molecular Geometry Information. J. Chem. Inf. Comput. Sci. 2004, 44, 2133–2144. [Google Scholar] [CrossRef]
- Taidakov, I.V.; Lobanov, A.N.; Lepnev, L.S.; Vitukhnovskii, A.G. Neodymium(III) Tris(1,3-Bis(1,3-Dimethyl-1H-Pyrazol-4-Yl)Propane-1,3-Dionato)(1,10-Phenanthroline): Synthesis and Photophysical Properties. Russ. J. Coord. Chem. 2014, 40, 16–22. [Google Scholar] [CrossRef]
- Metlina, D.A.; Metlin, M.T.; Ambrozevich, S.A.; Selyukov, A.S.; Datskevich, N.P.; Aminev, D.F.; Goryachii, D.O.; Lyssenko, K.A.; Pavlov, A.A.; Dmitrienko, A.O.; et al. Bright NIR-Luminescent Nd3+ Complexes with Pyrazole-Substituted 1,3-Diketones Demonstrated an Unusual Spectral Lines Branching Ratios. Dye Pigment. 2020, 181, 108558. [Google Scholar] [CrossRef]
- Dong, Y.; Li, G.; Li, L. Europium(III) Ion-Based Photoluminescence Complexes of Indole-Derivative β-Diketone Dominated by Ancillary Ligands. Inorganica Chim. Acta 2023, 556, 121616. [Google Scholar] [CrossRef]
- Gupta, A.; Sankaran, J.; Wohland, T. Fluorescence Correlation Spectroscopy: The Technique and Its Applications in Soft Matter. Phys. Sci. Rev. 2019, 4, 104. [Google Scholar] [CrossRef]
- Clegg, R.M. Chapter 1 Förster Resonance Energy Transfer—FRET What Is It, Why Do It, and How It’s Done. In Laboratory Techniques in Biochemistry and Molecular Biology; Elsevier: Amsterdam, The Netherlands, 2009; Volume 33, pp. 1–57. [Google Scholar] [CrossRef]
- Banerjee, A.; Blasiak, B.; Pasquier, E.; Tomanek, B.; Trudel, S. Synthesis, Characterization, and Evaluation of PEGylated First-Row Transition Metal Ferrite Nanoparticles as T2 Contrast Agents for High-Field MRI. RSC Adv. 2017, 7, 38125–38134. [Google Scholar] [CrossRef]
- Tóth, É.; Helm, L.; Merbach, A.E. Relaxivity of MRI Contrast Agents. In Contrast Agents I; Krause, W., De Meijere, A., Kessler, H., Ley, S.V., Thiem, J., Vögtle, F., Houk, K.N., Lehn, J.-M., Schreiber, S.L., Trost, B.M., et al., Eds.; Topics in Current Chemistry; Springer: Berlin/Heidelberg, Germany, 2002; Volume 221, pp. 61–101. [Google Scholar] [CrossRef]
- Farrugia, L.J. WinGX and ORTEP for Windows: An Update. J. Appl. Crystallogr. 2012, 45, 849–854. [Google Scholar] [CrossRef]
- Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
- Sheldrick, G.M. SHELXT–Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
- Nguyen, T.L.; Nguyen, T.H.; Nguyen, D.H. Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel. Int. J. Biomater. 2017, 2017, 8234712. [Google Scholar] [CrossRef]
- Ohishi, K.; Tsuchiya, K.; Ogura, T.; Ebisawa, A.; Sekine, A.; Masubuchi, Y.; Akamatsu, M.; Sakai, K.; Abe, M.; Sakai, H. Characterization of Lecithin Liposomes Prepared by Polyol Dilution Method Using 1,3-Butylene Glycol. Colloids Surf. A Physicochem. Eng. Asp. 2022, 650, 129592. [Google Scholar] [CrossRef]
- Ahmed, S.A.; Gaber, M.H.; Salama, A.A.; Ali, S.A. Efficacy of Copper Nanoparticles Encapsulated in Soya Lecithin Liposomes in Treating Breast Cancer Cells (MCF-7) in Vitro. Sci. Rep. 2023, 13, 15576. [Google Scholar] [CrossRef]
- Ahmed, S.A.; Salama, A.A.; Gaber, M.H.; Ali, S.A. Development and Characterization of Soy Lecithin Liposome as Potential Drug Carrier Systems for Doxorubicin. J. Pharm. Innov. 2023, 18, 1415–1426. [Google Scholar] [CrossRef]
- Anzini, P.; Redoglio, D.; Rocco, M.; Masciocchi, N.; Ferri, F. Light Scattering and Turbidimetry Techniques for the Characterization of Nanoparticles and Nanostructured Networks. Nanomaterials 2022, 12, 2214. [Google Scholar] [CrossRef] [PubMed]
- Anzini, P.; Bossuto, M.C.; Colombo, M.; Vivani, A.; Cherniukh, I.; Bodnarchuk, M.I.; Kovalenko, M.V.; Bertolotti, F.; Guagliardi, A.; Masciocchi, N.; et al. Simultaneous Dynamic Light Scattering, Absorbance and Photoluminescence Measurements of Colloidal Nanoparticles. Application to Colloidal Stability and Aggregation Kinetics of CsPbBr3 Nanocrystals. Small Methods 2025, 9, e00304. [Google Scholar] [CrossRef]
- Magatti, D.; Ferri, F. 25 Ns Software Correlator for Photon and Fluorescence Correlation Spectroscopy. Rev. Sci. Instrum. 2003, 74, 1135–1144. [Google Scholar] [CrossRef]
- Tinevez, J.-Y.; Perry, N.; Schindelin, J.; Hoopes, G.M.; Reynolds, G.D.; Laplantine, E.; Bednarek, S.Y.; Shorte, S.L.; Eliceiri, K.W. TrackMate: An Open and Extensible Platform for Single-Particle Tracking. Methods 2017, 115, 80–90. [Google Scholar] [CrossRef]
- Strömqvist, J.; Nardo, L.; Broekmans, O.; Kohn, J.; Lamperti, M.; Santamato, A.; Shalaby, M.; Sharma, G.; Di Trapani, P.; Bondani, M.; et al. Binding of Biotin to Streptavidin: A Combined Fluorescence Correlation Spectroscopy and Time-Resolved Fluorescence Study. Eur. Phys. J. Spec. Top. 2011, 199, 181–194. [Google Scholar] [CrossRef][Green Version]
- Nardo, L.; Re, F.; Brioschi, S.; Cazzaniga, E.; Orlando, A.; Minniti, S.; Lamperti, M.; Gregori, M.; Cassina, V.; Brogioli, D.; et al. Fluorimetric Detection of the Earliest Events in Amyloid β Oligomerization and Its Inhibition by Pharmacologically Active Liposomes. Biochim. Biophys. Acta (BBA)–Gen. Subj. 2016, 1860, 746–756. [Google Scholar] [CrossRef]
- Vesco, G.; Lualdi, M.; Fasano, M.; Nardo, L.; Alberio, T. Demonstration of Fibrinogen-FcRn Binding at Acidic pH by Means of Fluorescence Correlation Spectroscopy. Biochem. Biophys. Res. Commun. 2021, 536, 32–37. [Google Scholar] [CrossRef] [PubMed]
- Petrášek, Z.; Schwille, P. Precise Measurement of Diffusion Coefficients Using Scanning Fluorescence Correlation Spectroscopy. Biophys. J. 2008, 94, 1437–1448. [Google Scholar] [CrossRef] [PubMed]
- Elson, E.L.; Magde, D. Fluorescence Correlation Spectroscopy. I. Conceptual Basis and Theory. Biopolymers 1974, 13, 1–27. [Google Scholar] [CrossRef]
- Wu, B.; Chen, Y.; Müller, J.D. Fluorescence Correlation Spectroscopy of Finite-Sized Particles. Biophys. J. 2008, 94, 2800–2808. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Cicolari, D.; Santanni, F.; Grassi, L.; Brero, F.; Filibian, M.; Recca, T.; Arosio, P.; Perfetti, M.; Mariani, M.; Sessoli, R.; et al. Longitudinal and Transverse NMR Relaxivities of Ln(III)-DOTA Complexes: A Comprehensive Investigation. J. Chem. Phys. 2021, 155, 214201. [Google Scholar] [CrossRef]
- Hwang, L.; Freed, J.H. Dynamic Effects of Pair Correlation Functions on Spin Relaxation by Translational Diffusion in Liquids. J. Chem. Phys. 1975, 63, 4017–4025. [Google Scholar] [CrossRef]












| Entry | Wavelength (nm) | Transition 1 | Redshift (nm) 2 |
|---|---|---|---|
| 1 | 539 | LMCT | 99 |
| 2 | 389 | LLCT | 115 |
| 3 | 310 | LLCT | - |
| 4 | 275 | LLCT | - |
| D—H···A | D—H | H···A | D···A | D—H···A |
|---|---|---|---|---|
| C14—H14···O5 | 0.95 | 2.29 | 3.196 (4) | 160 |
| O5—H5O···O4i | 0.96 (1) | 2.27 (14) | 2.741 (3) | 109 (10) |
| O5—H5P···O4 | 0.96 (1) | 1.82 (4) | 2.741 (3) | 161 (11) |
| C35—H35C···O2ii | 0.98 | 2.59 | 3.476 (4) | 151 |
| r1 (mM−1 s−1) | r2 (mM−1 s−1) | r2/r1 |
|---|---|---|
| 1.92 | 52.3 | 27.2 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Vavassori, F.; Anzini, P.; Lamperti, M.; Uboldi, M.; Recchia, S.; Saibene, G.; Remori, V.; Tallarita, R.; Elvers, B.J.; Schulzke, C.; et al. Synthesis, Characterization, and Magnetic Properties of Fe(BIP)3, a Novel Paramagnetic Relaxation Agent. Pharmaceuticals 2026, 19, 221. https://doi.org/10.3390/ph19020221
Vavassori F, Anzini P, Lamperti M, Uboldi M, Recchia S, Saibene G, Remori V, Tallarita R, Elvers BJ, Schulzke C, et al. Synthesis, Characterization, and Magnetic Properties of Fe(BIP)3, a Novel Paramagnetic Relaxation Agent. Pharmaceuticals. 2026; 19(2):221. https://doi.org/10.3390/ph19020221
Chicago/Turabian StyleVavassori, Federico, Pietro Anzini, Marco Lamperti, Matteo Uboldi, Sandro Recchia, Giosuè Saibene, Veronica Remori, Roberto Tallarita, Benedict Josua Elvers, Carola Schulzke, and et al. 2026. "Synthesis, Characterization, and Magnetic Properties of Fe(BIP)3, a Novel Paramagnetic Relaxation Agent" Pharmaceuticals 19, no. 2: 221. https://doi.org/10.3390/ph19020221
APA StyleVavassori, F., Anzini, P., Lamperti, M., Uboldi, M., Recchia, S., Saibene, G., Remori, V., Tallarita, R., Elvers, B. J., Schulzke, C., Fasano, M., Penoni, A., Pettinato, V., Nardo, L., & Maspero, A. (2026). Synthesis, Characterization, and Magnetic Properties of Fe(BIP)3, a Novel Paramagnetic Relaxation Agent. Pharmaceuticals, 19(2), 221. https://doi.org/10.3390/ph19020221

